Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Calgary
$150,000.00
The Structural and Metabolic Changes Associated with Ependymal Layer Disruption in the Age Continuum of Hydrocephalus - A Human and Animal Model Study
EF 2017-18
Résumé
Hydrocephalus (HC) is a debilitating disease that affects 1 in 1000 Canadians. It afflicts all age groups, with infants being the most vulnerable. HC results from an over-accumulation of cerebrospinal fluid (CSF) in the brain. Untreated HC results in irreversible brain injury, disability and death. The only treatment is CSF diversion, typically via a shunt, 50% of which fail within the first two years.
A major hurdle in the advancement of care in HC has been the limited understanding of HC's pathophysiology. As a neurosurgeon, I have seen many patients die or maimed by HC, and convicted to now devote my life's work to it. As such, I have taken a leave of absence from my clinical duties to pursue a PhD in HC scientific research, after which I will return to practice. My goal is to become a surgeon-scientist, who will pioneer translational research in HC. My PhD is a dual university collaboration, which I helped establish between the University of Calgary (U of C) and Washington University (WUSTL).
The focused objective of my research is to characterize the cellular mechanisms of HC and identify molecular pathways that can be targeted for treatment. I will be using donated brains of deceased HC and non-HC patients across all age groups, from 12 centers worldwide. Recently, emerging evidence has implicated cells of the brain's ventricles where CSF is made, as a major component in the pathogenesis of HC. I will therefore leverage the resources and expertise at both U of C and WUSTL to study those cells in my samples. I will also use state-of-the-art brain imaging and CSF analysis technologies to identify potential biomarkers that may be used to diagnose and treat HC in at-risk individuals. In addition, I will create a novel mouse model of HC to cross-validate our findings, and establish it for future HC research. This multi-center study is first of its kind, and will lay the foundation for rigorously pursuing treatments that would curb this devastating disease.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
376678
Name
Isaacs Albert M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The Structural and Metabolic Changes Associated with Ependymal Layer Disruption in the Age Continuum of Hydrocephalus - A Human and Animal Model Study
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Arterial Spin Labelling; Brain Injury; Cell Adhesion Molecules; Cerebral Ventricles; Ependyma; Hydrocephalus; Hypoxia; Magnetic Resonance Imaging; Mitochondria Damage; Near-Infrared Spectroscopy
Abstract
Hydrocephalus (HC) is a debilitating disease that affects 1 in 1000 Canadians. It afflicts all age groups, with infants being the most vulnerable. HC results from an over-accumulation of cerebrospinal fluid (CSF) in the brain. Untreated HC results in irreversible brain injury, disability and death. The only treatment is CSF diversion, typically via a shunt, 50% of which fail within the first two years.
A major hurdle in the advancement of care in HC has been the limited understanding of HC's pathophysiology. As a neurosurgeon, I have seen many patients die or maimed by HC, and convicted to now devote my life's work to it. As such, I have taken a leave of absence from my clinical duties to pursue a PhD in HC scientific research, after which I will return to practice. My goal is to become a surgeon-scientist, who will pioneer translational research in HC. My PhD is a dual university collaboration, which I helped establish between the University of Calgary (U of C) and Washington University (WUSTL).
The focused objective of my research is to characterize the cellular mechanisms of HC and identify molecular pathways that can be targeted for treatment. I will be using donated brains of deceased HC and non-HC patients across all age groups, from 12 centers worldwide. Recently, emerging evidence has implicated cells of the brain's ventricles where CSF is made, as a major component in the pathogenesis of HC. I will therefore leverage the resources and expertise at both U of C and WUSTL to study those cells in my samples. I will also use state-of-the-art brain imaging and CSF analysis technologies to identify potential biomarkers that may be used to diagnose and treat HC in at-risk individuals. In addition, I will create a novel mouse model of HC to cross-validate our findings, and establish it for future HC research. This multi-center study is first of its kind, and will lay the foundation for rigorously pursuing treatments that would curb this devastating disease.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Isaacs, Albert M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~